Physician profile
Jonathan C Curtis
NPI 1053349472
$1,087.87
in general payments reported to CMS, 2019-2025
12 companies · $32.91 in 2025
The $32.91 reported for 2025 was less than what a typical Pediatric Dentistry provider received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2021: $117 · 2022: $180 · 2023: $128 · 2024: $17.29 · 2025: $32.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 3m Company | $511.56 | 2019 | |
| Ortho Organizers, INC. | $260.02 | 2022-2023 | Carriere |
| Colgate Oral Pharmaceuticals, INC. | $131.10 | 2021-2022 | |
| Henry Schein, INC. | $53.49 | 2019 | |
| Biolase, INC. | $35.23 | 2019 | |
| Solventum Corporation | $22.38 | 2025 | Clarity Aligners |
| Patterson Companies, INC. | $17.29 | 2024 | |
| Ultradent Products INC | $12.29 | 2019 | |
| Elevate Oral Care | $12.15 | 2021 | |
| Dentsply Sirona INC | $11.68 | 2021 | |
| Align Technology, INC. | $10.53 | 2025 | Invisalign |
| Coltene Whaledent INC. | $10.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.